InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: expediter13 post# 81021

Monday, 08/19/2013 11:20:31 AM

Monday, August 19, 2013 11:20:31 AM

Post# of 130504
The other option is that LymPro is licensed by Becton Dickinson and the share price moves above $1.00 and then Amgen enters into a license agreement to develop MANF and the share price moves over $5.00.

This doesn't happen to thousands of companies but it may well happen to "$AMBS".

Just saying.